ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

Site Search

You searched for "hepatitis D"

  • Angel Yen-Chun Liu, MD

    Physician, Department of gastroenterology and hepatology, Chang Gung Memorial Hospital, Linkou branch, Taiwan Dr. Yen-Chun Liu received M.D. degree from the Chang Gung University College of Medicine and are under Ph.D. program in Chang Gung University. Dr. Liu is a physician in Chang Gung Memorial Hospital, Linkou branch, Taiwan. Her clinical and research mainly focus on viral hepatitis, particularly in hepatitis B natural history and treatment.    Read the journal picks of the month from our Emerging Scholars Scientific and Medical Advisory Board here.  

    https://www.hepb.org/news-and-events/reports/emerging-scholars-scientific-and-medical-advisors/angel-yen-chun-liu-md/
  • Updates in Hepatitis B-related Liver Cancer Care

    Image courtesy of stockimages at FreeDigitalPhotos.net While liver cancer cases continue to climb in the U.S., so has the medical community’s ability to care for hepatitis B patients affected by liver cancer. Here are some updates and reminders to help you talk to your doctor and get the best care possible. What causes your cancer matters: Doctors often use a one-size-fits-all approach to treating liver cancer, no matter if it’s caused by hepatitis B or C. However, a new study suggests doctors should consider treating their hepatitis B cancer patients earlier and more aggressively than hepatitis C patients. Researchers monitored liver cancer in hundreds of hepatitis B and C patients over nine years and found hepatitis B patients developed cancer at a younger age and had more aggressive cancer. Hepatitis B patients: Had higher levels of alpha-fetoprotein (AFP), a blood test that indicates the presence of tumors Had liver cancer tumors that were larger and spread more quickly And often had portal thrombosis–a blockage in the vessel that delivers blood to the liver. Antivirals help prevent cancer recurrence after surgery and transplants: Treating liver cancer patients with antivirals after their tumors have been removed or after liver transplantation  clearly helps hepatitis B patients live longer. A growing number of studies show that treating transplant patients with antiviral drugs, which stop the virus from replicating, is improving survival because it stops the infection from returning. Treating patients with antivirals after their tumors are surgically removed or through chemoembolization, which blocks the blood supply to tumors, also extends patients’ lives. Treating depression is vital: Depression is very common in cancer patients and studies show 75 percent of cancer patients have untreated depression. While oncologists have not been very effective in referring patients to mental health providers, times are changing and linking patients to care

    http://www.hepb.org/blog/updates-in-hepatitis-b-related-liver-cancer-care/
  • HBV Journal Review - June 2015

    … hepatitis C patients, HBV patients: Had higher levels of alpha-fetoprotein (AFP), found through a blood test, which indicates the presence of tumors Had liver cancer tumors that grew and spread more quickly Had larger tumors And often had portal thrombosis–a blockage of the vessel that delivers blood to the liver from the intestines. However, hepatitis C patients with liver cancer had higher rates of cirrhosis, histories of alcohol and cigarette use and more diabetes than hepatitis B patients. The average survival rate for hepatitis B patients was 9.3 months after liver cancer diagnosis, compared to 10.9-month survival for hepatitis C patients. According to a related editorial published in the medical journal Oncology, about 700,000 patients are diagnosed with liver cancer each year worldwide; more than two-thirds of new cases result from HBV infection. Knowing HBV-related liver cancer is more aggressive can lead to different or accelerated treatment plans when patients are first diagnosed, the study's experts suggest. “This study provides more evidence that future clinical trials should stratify patients by hepatitis type to help identify better drugs and create personalized treatment modalities,” researcher Ahmed Kaseb explained. Source: http://newswise.com/articles/variations-in -liver-cancer-attributable-to-hepatitis-virus-variations Experts: Treat Cirrhotic Patients, Even if Viral Load Is Low Should "healthy" patients who have cirrhosis with low viral load and no signs of liver damage be treated? Absolutely, according to experts writing in the May issue of the medical journal Hepatology. Continue reading this review and the remainder of the June review here

    http://www.hepb.org/blog/hbv-journal-review-june-2015/
  • HBV Journal Review March 2015

    HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
 latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored: Cholesterol and Type 2 Diabetes Drugs Markedly Lower Cancer Risk in Hepatitis B Patients Hepatitis B Increases Risk of Stomach Cancer Unsafe Injections Caused 1.7 Million HBV Infections Worldwide in 2010 New Guidelines Require Doctors to Screen for Hepatitis B Before Starting Chemotherapy Computer Reminders Effective at Prompting Doctors to Screen for HBV Before Starting Chemotherapy Study Finds Getting Frequent Cancer Screenings Saves Lives Use of Radio Waves to Destroy Small Liver Tumors as Effective as Surgery Interferon Increases Thyroid Disease in Hepatitis B and C Patients Smoking Impairs Recovery from Hepatitis B and the Effectiveness of Immunization Hepatitis B Immunization Coverage Declined 2.1% in 2013 March 1, 2015 Volume 12, No 3 by Christine M. Kukka Cholesterol and Type 2 Diabetes Drugs Markedly Lower Cancer Risk in Hepatitis B Patients A large, ground-breaking study that followed 71,824 patients infected with the hepatitis B virus (HBV) from 2000 to 2008 found that those who took medium to high doses of metformin and/or statins had substantially lower rates of liver and other cancers. The study, conducted by Taiwanese researchers and published in the February issue of the journal Medicine, examined the impact of: Statins: Drugs taken to reduce triglycerides and cholesterol in the blood And metformin: A drug used to treat patients in the early stages of type 2 diabetes. There have been some studies that suggest statins reduce liver cancer risk in hepatitis B patients, however this large study that spanned eight years found a definite decrease in cancers in patients who took these drugs, especially at higher doses. While the exact mechanisms

    http://www.hepb.org/blog/hbv-journal-review-march-2015/
  • HBV Journal Review February 2015

    HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
 latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored: Quality of Care for Women with Hepatitis B Varies Dramatically Across U.S. One-third of HBeAg-negative Women Experience "Flares" After Childbirth Immunizing Newborns Is an Effective Tool in Preventing Cancer Experts Warn: Don't Delay Treatment in Patients with HBV Genotype C Antivirals Help Patients with Cirrhosis, If Started Early Enough Entecavir Effective at Clearing HBV's cccDNA from Liver Cells Older Age and a Weakened Immune System Can Cause HBV to Reactivate Survey Shows Doctors Fail to Adequately Screen for Liver Cancer Innovative Venues Increase Hepatitis B Screening Among Asian-Americans Study Finds Waste Collectors at High Risk of Hepatitis B Study Comparing Four Antivirals Finds All Appear Effective February 1, 2015 Volume 12, No 2 by Christine M. Kukka Quality of Care for Women with Hepatitis B Varies Dramatically Across U.S.  A U.S. Centers for Disease Control and Prevention study, published in the journal Infectious Diseases in Obstetrics and Gynecology, found a large discrepancy in medical treatment for women with hepatitis B-related liver disease. While scientific evidence shows antivirals are safe in pregnant women and effectively lower the risk of mother-to-child infection, American doctors prescribed antivirals to only 12.6% of pregnant women infected with the hepatitis B virus (HBV). In contrast, they prescribed antivirals to 20% of non-pregnant women. The important study examined prescription records of 17 million, privately-insured women in 2011. Researchers identified 6,274 women in the study group who were HBV-infected and examined what drugs were prescribed to treat their liver disease. Pregnant women were most commonly prescribed

    http://www.hepb.org/blog/hbv-journal-review-february-2015/
  • Physician Registration

    We invite qualified liver specialists who are knowledgeable about chronic hepatitis B to be listed in our Physician Directory. Please complete the form on the right to register. If you are already registered in our directory and would like to make a change to your information, please send an email to directory@hepb.org. Thank you for registering for our Physician Directory. We will review your request for approval. D-LIVR for HDV English Urdu No Translation services available None English Serves Spanish speaking patients English, Ghanaian languages (Ga-Adangbe, Twi) Azerbaijani, Russian, English English Serves Spanish speaking patients Yes. Tenofovir. Services also provided in Korean Services provided in English and Spanish. pegasys, peginteron, lamivudine, and recently tenefovir Arabic English IMMUNESUPPRESSION MEDICATIONSHEPATITIS C Yes, mainly hepatitis C agents Pegile Interferon Alpha All at UM. English STAT-C, Platelet Stimulating Growth Factors Services also provided in Vietnamese, Chinese, Arabic, and French. Clevudine, Tenofovir Translation services available Serves Veterans only. Written current textbook (2005) on treatment of hepatitis B. Provides services in English, Hindi and Punjabi Translation services available (all languages) HBV HCV ENGLISH Provides translation services Yes, contact office for additional information. Translation services available. English, Hindi, Punjabi Provides translation services Virahep-C Clevudine English No Provides translation services No Yes English, Romanian No Lamivudine, Adefovir, Tenofovir, Entecavir, Telbivudine various studies Provides services in English and various Chinese dialects. Services provided in English, Cantonese, Taiwanese, Mandarin, and Spanish No Services also provided in Spanish and Chinese. English Yes, Chronic Hep B and Chronic Hep C Services provided in Russian. English, French Entecavir Provides services in English and Spanish Jon Jon yes English Yes, contact office for additional information. Also at:San Jose Gastroenterology2340 Montpelier Drive, Ste ASan Jose, CA 95116 Preventing for mother to child hepatitis B transmission Mongolian English English Provides services for the hearing impaired as well as interpreting services Autologous prime-boost anti-tumor vaccination in patients with hepatoma or metastatic cancers (pancreas, neuroendocrine, gastric, colon, breast) to the cancer in the liverSorafenib pre-treatment in patients undergoing Hepatic Arterial Chemo-Embolization (HACE) for unresectable hepatoma to increase tumor kill. A Randomized, Double Blind, Placebo Controlled, Multicenter Phase 2 Study of VT-122 in Combination With Sorafenib Compared to Sorafenib With Placebo in Patients With Hepatocellular Carcinoma and Systemic Inflammation at Risk for CachexiaStudy of Gemcitabine/Abraxane + PEGPH20 vs Gemcitabine/Abraxane in Stage IV Previously Untreated Pancreatic Cancer Services provided in English and Spanish. English tenofovir Provides services in English and Vietnamese. Provides translation services lambda interferon, tenofovir and Peg IFN Chinese, Spanish, Russian Uzbek, English and Russian Lambda Interferon, Viread, Baraclude Services provided in English, Arabic, and Spanish No Arabic English NASH HDV PSC PBC Hebrew English yes yes yes yes Yes Available Translation services available (all languages) Yes Translators available for most languages (Cantonese, Mandarin, Spanish, Vietnamese, Korean) No N/A Provides services in English and Spanish Entecavir Provides services in English and Spanish Also at:San Jose Gastroenterology2340 Montpelier Drive, Ste ASan Jose, CA 95116 YES ROMANIAN ENGLISH HUNGARIAN ROMANIAN ENGLISH HUNGARIAN YES Romanian English Hungarian English, Spanish, Vietnamese, French Protease inhibitors & PI free regimens Spanish Hindi Urdu Vietnamese English Provided services in English and Spanish Entecavir Available for consultation and second opinions on liver biopsies and other pathologic specimens. No Yes. MKS172, tegobuvir, GS9457, GS5885 (all for hepatitis C) Interpretation services available for all languages Gilead HBV trial Physician only accepts new patients from other physicians Yes No English, have interpreter services No Interferon for Hepatitis BNucleoside Analogues Singapore Chapter ChairpersonACT HBV Asia Pacific Provides services in English, Spanish, Hindi, Urdu and Punjabi Yea Spanish, mandarin Services provided in all languages. Yes, contact office for additional information. Entecavir, Peginterferon Serves Spanish speaking patients PI for D-LIVR TRIAL Urdu, English Yes Urdu, English, Persian, Pushto, Baluchi Hepatitis B clinical trials with newer antiviral drugs. Also at:VA Greater Los Angeles Healthcare SystemDept. of Gastroenterology & Hepatology11301 Wilshire Blvd (111C)Los Angeles, CA 90099 Viread, Baraclude,Hepsena, Tyzeka, Interferon English Arabic No Yes Interpreter ServicesSupport Services for cancer patients and families No none Provides translator services I HAVE A FREE ONLINE CONSULTATION DESK ON FACE BOOK FOR FELLOWS RESIDENTS AND PATIENTS :GASTROENTEROLOGY CONSULTATION DESK We need deseminating information on HPB English, Swahili, French, Luganda, Lugwele Eastern Uganda, Langi Northern Uganda, Lunakitala Western Uganda, and etc. English Tamil Kannada Hindi Available English, Tamil, Hindi No Yes, contact office for additional information. Trials with new drugs on HCV, Hepatic encephalopathy, NASH Provides services in English, Spanish Currently 10 Contact office for information on clinical trials Advanced education in liver diseases at Yale University Provides translation services Entecavir English, Urdu English, French, Spanish, Portuguese Some fluence in German English, French, Spanish, Portuguese Some fluence in German Nepali, English, Japanese, Hindi, Bangla None yet English Various Nepali, English, Hindi, Bangla, Japanese English No Bangla, English Provides translation services No English, Korean Tolerance trials Provides translation services Yes, contact office for additional information. No hepatitis B trials. English, Mandarin, Cantonese, Chinese, and Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Yes English, Russian, Spanish Associate Professor of Medicine NIH multi-center Hepatitis B Group Provides translation services No Services also available in Chinese (Cantonese & Mandarin). Yes, contact office for additional information. No Services also provided in Vietnamese. Hep B/C treatment specialist. http://www.avvo.com/doctors/maximilian-lee-2743689.html Yes, contact office for additional information. Many. Fatty liver, hep B and C and D. Drug induced liver injury, acute liver failure. English. Spanish on site. Provides services in Chinese Yes, Entecavir Services provided in various languages. Lamivudine, Interferon, Peg, Telbivudine, Adefovir, Entecavir Provides service in Cantonese. Tenofovir and Truvada Services also provided in Vietnamese, Mandarin, Cantonese, and Spanish. Tenofovir No Hepatitis B Research Network English Provides services in English, Spanish and Chinese Yes, contact office for additional information. Professional Translation services available (all languages) AAHBP (Asian American Hepatitis B Program) Provides services in English, Spanish and Chinese Roche, Schering, Salix, Yes, contact office for additional information. Yes Services also provided in Spanish and Farsi. Services also provided in Arabic. No Services provided in English with accomodations Yes Services provided in all languages No Provides services in English and Spanish. Offers care for patients with polysubstance abuse and coinfections Numerous on HIV drugs including tenofovir (TDF)Now involved in phase 3 studies with tenofovir alefanomide (TAF) Long term Hepatitis B vaccine trials Nuc-stop, recruiting patients at St. Paul's Hospital Millennium Medical College English, Amharic, Oromifaa Services also provided in Spanish. Yes Urdu English Georgian, Russian, English Fax: 410-550-7861 Entecavir- Brystol Myers Squibb- currentAdefovir- GileadLamivudine- Smith Kline I follow a large number of children and adolescents with NASH, autoimmune hepatitis, hepatitis B and C. Entecavir NO Yes, contact office for additional information. Provides services in English, Spanish and Chinese Various Services provided in Russian and English. Novel therapies in the treatment of chronic hepatitis B and chronic hepatitis C Received Certificate of Recognition for the Management of Hepatitis B. Yes Full service interpretation with either in person or phone Hepatitis B/Hepatitis C English, French, Italian None currently. Yes - Entecavir, Peg INF, Adefovir, Tenofovir Services also provided in Vietnamese. Also at:San Jose Gastroenterology2340 Montpelier Drive, Ste ASan Jose, CA 95116 Also at:San Jose Gastroenterology2340 Montpelier Drive, Ste ASan Jose, CA 95116 Baraclude Services provided in English, Vietnamese, and Spanish Provides services using interpreters Services provided in English and Spanish English Provides services in English and Korean No Ukrainian, Russian, English Services also provided in Spanish. Provides services in English and Mandarin Provides services in English and Spanish No Yes Yes, contact office for additional information. Services also provided in Spanish.Author of " Dr. Melissa Palmer's Guide to Hepatitis and Liver Disease"Visit www.liverdisease.com Entecavir, Adefovir, Pegasys, Peg-intron Provides services in English, Mandarin, Cantonese and Korean 19 rum No Yes Interpreter ServicesSupport Services for cancer patients and families Hsbag English No Yes, contact office for additional information. No active trials. None Provides services in English and Spanish Teleprivir, Boceprevir None at the moment English, German English, Spanish No Spanish, Portuguese Provides services in English, Spanish and Chinese Yes, contact office for additional information. Translation services available. Viread, Barraclude No Services also provided in Spanish and Hindi. Sorafenib, Entecavir Yes English Tenofovir, IFN Test No Languages. No New medication for hepatocellular carcinoma Entecavir/NIH HBV Consortium All with translation services Clinical Trials for HBV and HCV English English Hindi Telugu Tenofovir, Peg-Interferon Comparing Tenofovir vs Truvada for slow responders Yearly lecture at Uinveristy of Virginia regarding HBV HCV, HBV, NASH, fibrosis oral antiviral drugs interferons hep B vaccine pashto dari persien urdo english none Provides services in English and Spanish No English Services also provided in Mandarin and Spanish. No Yes Spanish, Mandarin, Cantonese Hepatitis B trials at the Center for Liver Diseases and University of Miami. Contact office for details English, Spanish Past work with Tenofovir/Entacivir Provides translation services Pediatric entecavir Provides translation services available Spanish, English available Spanish, English for HCV. English, Cantonese, Mandarin combination of drugs Provides translator services Dr. Shahrier's training includes transplant hepatology and currently cares for the highest number of patients with liver disease in eastern North Carolina Yes, call office for additional information. Services also provided in Spanish, Hindi, and Punjabi. Entecavir Yes All 1. Anal Albendazole for Pruritus ani due to Enterobiasis 2. Metadoxin in NAFLD3. High Dose UDCA in NAFLD I am interested in preventive Hepatology. Working more in the field of public awareness campaigns for Hep B. Organizing Hepatitis B Eradication Day on 28th July every year since 2001. entecavir Provides translation services Provides translation services hepavir B Cambodian and some English Yes No Services provided in English and Spanish. Multiple Provides services in English and Spanish regional trial of Lamiudine, Cimatidine and many others Works as CEO & Principal of Allama Iqbal Medical College. President of Pakistan Society of Hepatology. Founder of Pakistan Society of Gastroenterology ENGLISH Services also provided in Filipino. Mailing Address: University of Chicago Medical Center5841 S. Maryland Ave, MC 7120Chicago, IL 60637 Not Yet Started 1st and 2nd line HCC trials Chinese translator available. Provides translator services DEB, Abbot, and Roche drugs HCV, HBV, Hepatic Encephalopathy, IBD/IBS Nucleotide Analogs, Tenofovir, Entecavir Also at:San Jose Gastroenterology2340 Montpelier Drive,Ste ASan Jose, CA 95116 Pegasys, Entecavir, Tenofovir English, Mandarin, Taiwanese, Japanese Hepatitis Delta International Registry, Primary Immunodeficiency in adults Romanian, Russian, English Provides services in English, Spanish, Greek, Italian and French Entecavir, PEG-IFN, Ribavirin, none currently english, spanish, french english, spanish, french Newer drugs in Hepatitis C, Post liver transplanation anti HBV drugs efficacy English, Tamil Yes Hep B, Hep C, Hepatic Encephalopathy Yes Provides services in English, Spanish, Italian, Russian and Tagulog BMS #A1463-085 Provides services in English and Spanish. Yes Interpreter ServicesSupport Services for cancer patients and families Pediatric Hepatitis B trials ongoing Chinese, in person interpreter provided for all other common languages Provides services in English, Spanish and Chinese Provides services in English and Spanish Provides free interpretation services in Korean, Chinese, Vietnamese, Urdu, etc. Yes Urdu, English Clinical - mostly about HCV Epidemiological - HBV Georgian (Native) English (fluent) Russian (good) Interferon Lambda Translation services available. Translation services available. Adeforvir, enticavoir, lamvudine, telibivudine, tenofovir, peglated interferon Services provided in English and Chinese

    https://www.hepb.org/treatment-and-management/physician-directory/physician-registration/
  • Arrowhead’s HBV Candidate Requires Further Dose Escalation

    It should be noted while numerically the improvement in knockdown from 1mg/kg to 2mg/kg was only 12%, this is likely the result of the apparent high variability at the lower dose level with the increased tightness of the knockdown range at 2mg/kg indicating that the RNAi mechanism is starting to be solidly engaged with the expectation of a steepening dose response going forward. Sadly, we read that Phase 2a data presented by Arrowhead fell short of expectations for their ARC-520 drug to treat chronic hepatitis B. Hopefully dose escalation to 4mg/kg will result in both effective and safe results. However, there are others in the race for the cure, and may the most effective and safe drug soon result in a functional cure for chronic HBV. ~ hepbtalk   Harnessing the Power of RNAi Gene Silencing in Quest of a Cure for Chronic Hepatitis B, and the HBV KnockDown blog written by Dirk Haussecker, who believes it's about time everyone got serious about a functional cure for hepatitis B.  Be sure to visit Dirk Haussecker's blog !   Today, we learned about some hard HBsAg knockdown numbers from the phase IIa Hong Kong study of ARC520 in chronically infected HBV patients.  The data relate to the first 2 cohorts in this ongoing dose escalation trial.  Accordingly, the mean HBsAg knockdown at nadir for the starting dose of 1mg/kg was 39% within a range of 22-57%(n=6) while it was 51% within a range of 46-59% for the 2mg/kg cohort (n=6). ARC520 was given as a single dose to patients already stably on polymerase inhibitor entecavir. While clearly missing the company’s own guidance of a 1 log reduction at 2mg/kg, the good safety profile-no SAEs at all in the study with all AEs rated to be unrelated to ARC520- in addition to the steepening dose-response curve following 2mg/kg means that ARC520 is far from being out of the HBV knockdown race.  Still, the stock market over-reacted, punishing ARWR stock with a percent decrease that matched the reported

    http://www.hepb.org/blog/arrowheads-hbv-candidate-requires-further-dose-escalation/
  • Two Powerful Editorials Published by the Hepatitis B Foundation

    Doylestown, Pa., May 30, 2020 -- We have published two new editorials in honor of Hepatitis Awareness Month (May). One is a very informational editorial about the importance of a cure by HBF President Timothy Block and SVP Chari Cohen, posted here: www.futureofpersonalheath.com. The other is an excellent editorial written by HBF storyteller David about living with HBV in the time of COVID, posted here: www.futureofpersonalhealth.com.  

    https://www.hepb.org/news-and-events/news-2/two-powerful-editorial-published-by-the-hepatitis-b-foundation/
  • Talking with Your Doctor About Clinical Trials

    It is important to make an informed decision when considering a clinical trial, and talking to your doctor should be part of this process. Bring the information about any trials with you when you visit your doctor, so you can discuss the pros and cons of each. Your doctor should be able to help explain the process of joining a clinical trial, and you can make a shared decision about what is best for you. Remember that when you join a clinical trial, you will be working with the health care team that is associated with the trial – this might mean seeing a different doctor than you do now. Be sure to coordinate your care among your doctors.  Your Doctor's Role in Clinical Trials Talk to your doctor about clinical trials that may benefit you. Ask your doctor to help you sort through the pros and cons of enrolling in a clinical trial and the different treatment options. Be sure to ask about whether the drug being tested is better or riskier for you than no treatment.  Is it better than existing treatments that are already approved? Although you can leave a clinical trial at any time, be sure to let the doctor or nurse know why you want to leave. You are also encouraged to see your primary health care provider on a regular basis even if you are in a clinical trial. 10 Questions to Ask Your Doctor Before Enrolling in a Clinical Trial Where is the site located and how often will I need to go there? Will I be charged for any part of the trial or will my insurance pay for it? Why do researchers think the treatment will work better than standard (FDA-approved) treatment? Who is most likely to benefit from this drug? How many people have tested the drug and what has happened to them? What are the possible short and long-term side effects? What tests or procedures are involved and how are patients safely monitored while on the treatment? What happens to my hepatitis B when I stop taking the drug? What is the follow-up care after the clinical trial ends? If this drug doesn't work for me, am I eligible to try another one?

    https://www.hepb.org/treatment-and-management/clinical-trials/ask-a-doctor/
  • Hindi

    हेपेटाईटिस बी फाउन्डेशन वेबसाईट के हिंदी चेप्टर में आपका स्वागत है| हेपेटाईटिस बी, एक शांत रोग के तौर पर जाना जाता है, और कई लोगों को तो पता तक नहीं कि वे इस रोग से ग्रस्त / संक्रमित हैं। नीचे दी गई महत्वपूर्ण जानकारी अपने मित्रों, परिवार और अपने समुदाय के लोगों को और अन्य लोगों को बताऐं । -        इस रोग के लिए सुरक्षित वेकसीन उपलब्ध है। -        ख़ून की केवल  सादी सी जाँच करानी होती है। -        चिकित्सा के विकल्प उपलब्ध हैं। -        हेपेटाईटिस बी, वंशगत रोग नहीं है – यह एक वायरस / विषाणु के कारण होता है। हेपेटाईटिस बी फाउन्डेशन एक राष्ट्रीय, मुनाफे बग़ैर काम करने वाली संस्था है, जिसका उद्देश इस रोग की चिकित्सा के लिए संशोधन करना है, और हेपेटाईटिस बी के संक्रमण ग्रस्त लोगों के जीवन की गुणवत्ता के सुधार ने में सहायता करना है। उन सभी के लिए जो उस रोग से विश्वभर में असरग्रस्त हैं, संशोधन, शिक्षा और मरीज़ों की सहायता  द्वारा उनके जीवन की गुणवत्ता को सुधारना है। अस्वीकृत करना : इस वेबसाइट पर दी गई जानकारी केवल शिक्षा के हेतु से दी गई है। हेपेटाईटिस बी फाउन्डेशन कोई मेडिकल संस्था नहीं है। अपनी नीजि चिकित्सा के लिए और सलाह के लिए अपने डाक्टर से बात करें या किसी योग्य चिकित्सक से बात करें।  Welcome to the Hindi Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and many people don’t even know they are infected. Please share the following important information with your friends, family and others in your community - There is a safe vaccine.  - There is a simple blood test.  - There are treatment options. - Hepatitis B is not inherited - it is caused by a virus.  The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice. 

    https://www.hepb.org/languages/hindi/